OROPHARYNGEAL P16INK4A-NEGATIVE SQUAMOUS CELL CARCINOMA

Clinical trials for OROPHARYNGEAL P16INK4A-NEGATIVE SQUAMOUS CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new OROPHARYNGEAL P16INK4A-NEGATIVE SQUAMOUS CELL CARCINOMA trials appear

Sign up with your email to follow new studies for OROPHARYNGEAL P16INK4A-NEGATIVE SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Major trial tests new weapons against aggressive head and neck cancers

Disease control Recruiting now

This study is for patients who have had surgery for high-risk head and neck cancer. It aims to find the best combination of radiation and drugs to prevent the cancer from coming back. Researchers are comparing the standard treatment (radiation with cisplatin) to two newer approac…

Matched conditions: OROPHARYNGEAL P16INK4A-NEGATIVE SQUAMOUS CELL CARCINOMA

Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

OROPHARYNGEAL P16INK4A-NEGATIVE SQUAMOUS CELL CARCINOMA

Get alerted when new OROPHARYNGEAL P16INK4A-NEGATIVE SQUAMOUS CELL CARCINOMA trials appear

Major trial tests new weapons against aggressive head and neck cancers